Our understanding of epigenetics has been transformed in recent years by the advance of technological possibilities based primarily on a powerful tool, chromatin immunoprecipitation (ChIP). However, in many cases, the detection of epigenetic changes requires methods providing a high-throughput (HTP) platform. Cytometry has opened a novel approach for the quantitative measurement of molecules, including PCR products, anchored to appropriately addressed microbeads (Pataki et al. 2005 . Cytometry 68, 45-52). Here we show selected examples for the utility of two different cytometry-based platforms of epigenetic analysis: ChIP-on-beads, a flow-cytometric test of local histone modifications (Balint et al. 2005. Mol. Cell Biol. 25, 5648-5663), and the laser scanning cytometry-based measurement of global epigenetic modifications that might help predict clinical behavior in different pathological conditions. We anticipate that such alternative tools may shortly become indispensable in clinical practice, translating the systematic screening of epigenetic tags from basic research into routine diagnostics of HTP demand.
Introduction
Epigenetic changes associated with gene regulation play a major role in the establishment of altered differentiation states (3) . Specific modifications often correlate with gene activation or repression; for instance H3K4ac and H3K4me3 are permissive for gene activation whereas H3K9me2, H3K27me3, and methylation of CpG islands in promoter regions correlate with transcriptional silencing. Often, activating and repressive marks co-exist at gene start sites, reflecting perhaps epigenetic heterogeneity among otherwise similar cells, establishing a fine balance that could determine the gene expression patterns in the tissue. 
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The 'epigenetic code' has become an indispensable concept in basic research, and its principles are also utilized to develop drugs and diagnostic tools. Several genes being epigenetically misregulated have been shown to associate with different kinds of cancer, highlighting the role of the 'language' of covalent modifications in tumorigenesis (4, 5) . For instance, based on the patterns of modifications, two disease subtypes with different risks of tumor recurrence have been characterized in prostate cancer patients, independently from tumor stage, preoperative prostate-specific antigen levels, and capsule invasion (6) .
The chromatin of cancer cells often exhibits both an overall (global) DNA hypomethylation and hypermethylation of specific regions, leading to 'DNA methylation imbalance' (7) . The recurrence of global DNA hypomethylation in many types of human cancer is suggestive of its significant role in carcinogenesis, perhaps by inducing genomic instability and/or activating oncogenes (8, 9) . However, global hypomethylation is subject to a high degree of variability, unaccounted for by our current level of understanding (10, 11) . In addition to neoplastic transformation, problems of epigenetic regulation, including CpG methylation disorders are also involved in a wide range of pathological phenomena (12, 13) . In most eukaryotes, methylation of DNA occurs at the cytosine residues of cytosine-phospho-guanine (CpG) dinucleotides. The enzymes responsible for the production of 5-methylcytosine (5-mc) involving the fifth carbon atom of cytosine in CpG dinucleotides are the DNA methyltransferases DNMT1, DNMT3a, and DNMT3b, of which the first is involved in the maintenance of methylation during DNA replication, while all appear to be important in the establishment of methylation patterns in most physiological and pathological settings (14-16).
Flow-and Laser Scanning Cytometry in Epigenetics Research
Our understanding of epigenetics has been transformed in recent years by a succession of technological innovations. Approaches involving microarrays and, most recently ultra-high throughput (deep) sequencing technology have been applied to map cytosine methylation, chromatin modifications, and ncRNAs across entire genomes. Genome-scale studies of histone modifications and other aspects of chromatin structure typically rely on an immunological procedure, chromatin immunoprecipitation (ChIP) (17) , in which specific antibodies are used to enrich chromatin. ChIP is a powerful tool in epigenetics; however, in many cases the detection of epigenetic changes or transcription factor binding associated with the regulation of certain genes would require ChIP-based methods that provide high-throughput (HTP) potential. Monitoring local as well as global changes of epigenetic markers could be extremely useful in diagnostics as well as in basic research.
Flow-cytometric analysis provides a novel means for the quantitative measurement of molecules also in cell-free solutions, anchoring them to appropriately addressed microbeads. The utility and power
approach has been demonstrated in the case of various assays of molecular diagnostic value: immunoassays, sensitive measurement of protease or nuclease activity, detection of deletion/insertion of sequences by heteroduplex analysis, etc., that could all be adapted to a 'lab-on-beads' platform, i.e., the flow-cytometric analysis of microbead-captured macromolecules (1, 18, 19) . Many samples can be simultaneously analyzed in a FACSarray instrument using fluorescent dyes matching its optical channels.
Beyond lending a HTP platform for the analysis of genespecific epigenetic markers, cytometry also makes global analysis of epigenetic changes possible, most conveniently in its on-slide format, by microscope-based cytometers. Laser scanning cytometry (LSC) provides a robust method for analyzing single-cell events on slides (20, 21) . It generates quantitative fluorescence data similar to flow cytometry, but the analyzed cells are attached to the surfaces of microscopic slides or culture chambers. The main advantages of LSC are that (i) the possible correlation between the simultaneously measured parameters is detected at the individual cell resolution, i.e., with a sensitivity surpassing that of flow cytometry; (ii) the instrument is able to relocate each cell for additional measurements, thus the analysis of functional features of live cells can be combined with measurements that require fixed cells; and (iii) measurements can be performed in an automated fashion, preprogrammed for several slides.
Examples highlighted in this review demonstrate the value of two different HTP platforms for epigenetic analysis, namely ChIPon-beads and assessment of global epigenetic traits by LSC. These methods might help introduce systematic screening of different epigenetic tags into clinical practice, especially of those that correlate with therapeutic success. It will be shown that sequencespecific capture of PCR-amplified ChIP-fragments on microbeads allows a robust detection of histone-tail modifications in the promoter region of a well-characterized gene, tissue transglutaminase type 2 (TGM2). We also assess the prospects of laser scanning cytometry for the analysis of epigenetic changes involving the whole genome via the example of a global DNA methylation test.
High-Throughput Screening of Local Epigenetic Changes by ChIP-on-Beads
We have investigated the cellular levels of H4K acetylation and H3K4 methylation of the histone tails at the promoter of the TGM2 gene, to test whether these covalent modifications can be detected using a flow-cytometric platform. As shown earlier (2)and briefly recapped herein, the flow-ChIP method, nicknamed ChIP-on-beads, can be easily implemented in a routine flow-cytometric clinical laboratory without relying on real-time QPCR. In the ChIP-on-beads assay, a standard ChIP is performed and then this DNA is used as template in an end-point PCR reaction. The sense and anti-sense primers are tagged at their 5 0 ends with fluorescent dyes (e.g., Fam, Cy3) and biotin,
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respectively. Small aliquots of the Fam/biotin-ended PCR products are then bound to streptavidin-conjugated microbeads and quantified by flow cytometry. Of note, PCRs must be stopped in the linear phase to ensure reliable quantification; this should be initially determined in pilot QPCR experiments. The similarity of data obtained by QPCR and by flow cytometry has been shown (2).
As shown in Fig.7 .1A, the fluorescence intensity of the microbeads increases linearly with the quantity of the fluoresceinated PCR products added, allowing the expression of ChIP-PCR 
yields as absolute copy numbers. The flow-cytometric fluorescence distribution means are used to calculate the fraction of DNA copy numbers in the ChIP samples relative to the input DNA ( Fig.7.1B) . Comparing control and early-apoptotic Jurkat cells for changes in the level of H4Kac and H3K4me within the promoter of TGM2, we observed a significant decrease in both histone modifications (Fig.7.1C) , suggestive of the closure of chromatin structure early upon apoptosis. In comparison, the observed histone modifications at exon 9 of the MLLgene, used as positive control, were in accordance with its known histone-code profile (22) ; in contrast, the b-globin gene, used as negative control, gave <0.1% Ab/input ratios (not shown).
Testing Global Epigenetic Changes by Laser Scanning Microscopy: Studies on DNA Methylation
It is often important to consider in what global context local epigenetic changes occur (23) . Moreover, global changes of certain epigenetic modifications may have their independent diagnostic value, especially when analyzed in correlation with other phenotypic markers, an opportunity offered by up-to-date laser scanning microscopic systems (20, 21) . Development of antibodies and chimeric methyl CpG-binding antibody-like proteins (24) (25) (26) (27) , both recognizing CpG with high specificity, has opened novel perspectives for the diagnostic analysis of global methylation states. Anti-5mC antibodies are commercially available through various sources (e.g., Abcam and Biocarta US).
In experiments using the recombinant mCpG-binding antibody-like MBD-Fc protein (26) (27) (28) , the overall level of CpG methylation has been quantified in the HCT116 cell line (Fig.7.2) . As shown by confocal laser scanning microscopy 
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(CLSM), mCpGs have been efficiently labeled by indirect immunofluorescence in DNMT1/3b wild-type and, to a lesser extent, DNMT/3b double knock-out cells. The level of mCpGs has been quantified in a sizable population of cells by an iCys laser scanning cytometer and iCyte 2.6 software (CompuCyte, USA). As shown in Fig.7.2 , the fluorescence distributions of the Alexa546-labeled mCpGs are significantly different in the DNMT1/3b +/À cells; this result demonstrates the utility of LSC for the fine assessment of global methylation states in different cell types (e.g., differentiated vs. stem cells) or in a specific cell type (e.g., in human peripheral lymphocytes isolated from blood samples) before and after drug treatment or chemotherapy. Since LSC can be performed in an automated fashion, such studies could be made on large sets of biopsy material so as to establish the exact role of global DNA methylation in human pathological diagnosis of various diseases.
Data presented herein have demonstrated that if combined, flow cytometry and conventional PCR offer a powerful tool in the quantitative analysis of ChIP results. We have found high levels of H4Kac and H3K4me at the TGM2gene core promoter (Fig.7.1 ). These levels significantly decreased upon apoptosis and this was accompanied by the down-regulation of TGM2 mRNA expression (2), suggesting that this enzyme does not contribute to the early manifestations of apoptosis in Jurkat cells. Differences in the global level of DNA methylation in HCT116 wild-type and methylation defective cells have been revealed by LSC, the on-slide version of flow cytometry (Fig.7.2 ). Both assays can be easily implemented, and readily applied in a HTP format. We envisage the utility of these platforms primarily in clinical screening efforts addressing one, or a few, epigenetic markers in many samples simultaneously, depending on cost/time considerations and availability of instrumentation/expertise.
Although the epigenetic changes are heritable, they appear to be readily reversed by specific drug treatments as opposed to gene mutations. We expect that the epigenetic silencing of, e.g., tumor suppressor genes will soon become a frequent target of HTP screening studies because these mechanisms may be as important in carcinogenesis as the inactivating mutations. Drugs targeting the enzymes that remove or add these chemical tags are at the forefront of research: diseases to be targeted include cancer, imprinting disorders, autoimmune diseases, certain neurological disorders, diabetes, cardiopulmonary diseases, in which mis-steps in epigenetic programming have been directly implicated. Pharmaceutical companies have set up programs on histone decacetylases (HDACs) and DNA methyltransferases (DNMTs) and their inhibitors, as they have the potential to re-activate specific tumor suppressor genes; clinical trials being on the way are promising the prospect of eliciting tumor regression by modulation of epigenetic regulation.
Based on the above, we anticipate that epigenetic analysis will enter routine diagnostic practice whenever monitoring epigenetic markers can help predict clinical behavior. When large sets of samples are to be assessed, high-throughput platforms for the accurate evaluation of the ChIP results are of general interest. In view of the fact that most routine techniques can be adapted to flow cytometry which exceeds more conventional methods in sensitivity and reproducibility, the approaches shown can provide a universal platform for almost any kind of lab purposes. Whether ChIP-QPCR, ChIP-on-beads, or LSC-based assays of global epigenetic changes will be selected as the approach of choice for such screening projects will be determined by the particular task undertaken, and the capabilities of the clinical laboratories. We believe that these alternative ChIP platforms can help bring epigenetic analysis within reach for routine laboratories, especially for those involved in clinical diagnostics. 12. Streptavidin-coated microbeads (6 mm, Polyscience). 3. Resuspend cells in 1 mL of nucleus isolation buffer and incubate them for 10 min on ice. Vortex tubes in every 2-3 min.
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4. Centrifuge isolated nuclei at 500g for 3 min, at 4°C. Resuspend pellet in 500 mL sonication buffer.
5. Sonicate chromatin to an average fragment size of 500 bp using a Bioruptor (Diagenode); 0.5 min ON/0.5 min OFF pulses for 2 Â 12 min usually produces the desired size distribution.
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6. Centrifuge sheared chromatin samples at maximum speed for 20 min. Keep supernatants (leave 50 mL on the bottom of the tubes). Freeze in liquid nitrogen and store samples at -80°C (or proceed immediately).
7. Thaw samples on ice and centrifuge them at maximum speed for 10 min at 4°C. Transfer supernatants into clean tubes (do not disturb pellet on the bottom of the tubes).
8. Dilute chromatin samples 1:10 in IP buffer as follows: 100 mL chromatin 900 mL IP buffer.
9. Pre-clear samples by incubating them on a rotating wheel with 30 mL of blocked protein A/G Sepharose for 30 min at 4°C. Spin samples at 500g for 3 min at 4°C. Keep supernatants.
10. Perform immunoselection for >12 h on a rotating wheel by adding the following antibodies to the samples: anti-H4Kac and anti-H3K4me2; as negative control, omit specific Ab but add a specific IgG protein from the same isotype to one of the pre-cleared samples.
11. Preserve 10 mL from the 'negative control' as 'input' DNA and store it at -20°C. Collect immune complexes by adding 40 mL of blocked protein A/G Sepharose to each sample and incubate them for 45 min on a rotator. Spin samples at 500g for 3 min.
12. Wash the pelleted immune complexes as follows: 2 Â WB A, 2 Â WB B, 2 Â WB C, 1 Â TE. Resuspend pellets in 500 mL TE. At this point thaw input DNA and dilute it to 500 mL; process it together with the IP samples.
13. Reverse cross-links by incubating the samples at 98°C for 10 min. Put samples on ice.
14. Digest residual RNAs with 200 mg/mL RNase A for 30 min at 37°C.
15. Digest proteins by 0.5 mg/mL proteinase K for at least 2 h at 55°C. 
Purify DNA on PCR clean-up columns (Qiagen
Notes
1. MCpGs have been visualized using a Zeiss LSM 510 confocal laser-scanning microscope using excitation wavelengths of 543 and 351/364 nm. Fluorescence emission was detected through 560-615 and 385-470 nm band-pass filters. Images were taken in multitrack mode to prevent cross-talk between the channels. Pixel image (512 Â 512) stacks of 2-2.5 mm thick optical sections were obtained with a 63 Â PlanApochromat oil immersion objective (NA 1.4). The same samples were also analyzed using an iCys laser scanning cytometer (CompuCyte). The instrument used in our studies is equipped with a violet-blue diode, an argon-ion, and a HeNe laser (wavelengths 405, 488, and 633 nm, respectively). The violet and Ar-ion laser lines were used for excitation of Hoechst and Alexa 546 dyes. To identify single nuclei, contouring was based on Hoechst fluorescence detected in the blue channel (460-485 nm). Fluorescence of Alexa 546 (MCpGs) was detected in the orange channel (565-585 nm) based on the contour gained in the blue channel. In single nuclei identified by contouring on fluorescence of the nuclear stain, the integral fluorescence related to the MCpGs divided by the area of the contour was used to describe the methylation level. This corrects for differences in nuclear size. Data evaluation and hardware control were performed using the iCys 2.6 software for Windows XP. Using the 4 Â objective to scan an indicated area on a slide, 400-1000 cells were scanned in about 10 min (21) . LSC can screen relatively large number of cells on a slide. The cells are distinguished
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based on their fluorescence properties like in flow cytometry. However, as the position of each cell is fixed on the slide and the instrument saves the positional information, any correlation between the different parameters measured can be detected in a very sensitive manner. In addition, the cells can be relocated and visually analyzed or re-scanned after re-staining with conventional stains or fluorescent markers.
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